Annahita Keravala

Annahita Keravala

Company: CODA Biotherapeutics

Job title: Senior Vice President, Head of Gene Therapy


Targeted CODA Receptor Expression to Regulate Aberrant Neuronal Circuits in mTLE 10:15 am

Targeted CODA-receptor expression for mTLE using next-gen AAV vectors Highlighting AAV capsid selection criteria for epilepsy target cells Optimising the AAV expression cassette Sharing preliminary data in two models of focal epilepsyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.